Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
President Donald Trump unveils TrumpRx.gov with 16 pharmaceutical companies slashing prescription drug prices, including Wegovy, dropping from $1,300 to $199 monthly.
Mindbodygreen's recall covers 148,370 Ultimate Multivitamin+ bottles due to non-child-resistant packaging that could result in the poisoning of a young child.
Obamacare enrollment projected to drop by over 1 million Americans as health insurance premiums surge following the end of COVID-era federal subsidies in 2026.